{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:17:52Z","timestamp":1791253072303,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00401-010-0742-6","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T10:38:49Z","timestamp":1283769529000},"page":"777-788","source":"Crossref","is-referenced-by-count":105,"title":["Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses"],"prefix":"10.1007","volume":"120","author":[{"given":"Sanaz","family":"Gabery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement T.","family":"Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McCusker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"742_CR1","doi-asserted-by":"crossref","unstructured":"(1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72:971\u2013983","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"742_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tem.2008.08.007","volume":"19","author":"A Adamantidis","year":"2008","unstructured":"Adamantidis A, de Lecea L (2008) Sleep and metabolism: shared circuits, new connections. Trends Endocrinol Metab 19:362\u2013370","journal-title":"Trends Endocrinol Metab"},{"key":"742_CR3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","volume":"65","author":"I Arnulf","year":"2008","unstructured":"Arnulf I, Nielsen J, Lohmann E et al (2008) Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 65:482\u2013488","journal-title":"Arch Neurol"},{"key":"742_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","volume":"18","author":"A Aziz","year":"2008","unstructured":"Aziz A, Fronczek R, Maat-Schieman M et al (2008) Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol 18:474\u2013483","journal-title":"Brain Pathol"},{"key":"742_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2010.02.009","volume":"16","author":"NA Aziz","year":"2010","unstructured":"Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RA (2010) Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington\u2019s disease. Parkinsonism Relat Disord 16:345\u2013350","journal-title":"Parkinsonism Relat Disord"},{"key":"742_CR6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1468-1331.2010.02973.x","volume":"17","author":"NA Aziz","year":"2010","unstructured":"Aziz NA, Anguelova GV, Marinus J, van Dijk JG, Roos RA (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington\u2019s disease. Eur J Neurol 17:1068\u20131074","journal-title":"Eur J Neurol"},{"key":"742_CR7","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Frolich M et al (2009) Increased hypothalamic\u2013pituitary\u2013adrenal axis activity in Huntington\u2019s disease. J Clin Endocrinol Metab 94:1223\u20131228","journal-title":"J Clin Endocrinol Metab"},{"key":"742_CR8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brainresrev.2007.04.005","volume":"57","author":"AM Bao","year":"2008","unstructured":"Bao AM, Meynen G, Swaab DF (2008) The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 57:531\u2013553","journal-title":"Brain Res Rev"},{"key":"742_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/260536a0","volume":"260","author":"ED Bird","year":"1976","unstructured":"Bird ED, Chiappa SA, Fink G (1976) Brain immunoreactive gonadotropin-releasing hormone in Huntington\u2019s chorea and in non-choreic subjects. Nature 260:536\u2013538","journal-title":"Nature"},{"key":"742_CR10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/mds.21447","volume":"22","author":"M Bjorkqvist","year":"2007","unstructured":"Bjorkqvist M, Leavitt BR, Nielsen JE et al (2007) Cocaine- and amphetamine-regulated transcript is increased in Huntington disease. Mov Disord 22:1952\u20131954","journal-title":"Mov Disord"},{"key":"742_CR11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","volume":"15","author":"M Bjorkqvist","year":"2006","unstructured":"Bjorkqvist M, Petersen A, Bacos K et al (2006) Progressive alterations in the hypothalamic\u2013pituitary\u2013adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 15:1713\u20131721","journal-title":"Hum Mol Genet"},{"key":"742_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-8993(98)00578-2","volume":"802","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E (1998) Pick\u2019s disease: cytoskeletal changes in the hypothalamic lateral tuberal nucleus. Brain Res 802:119\u2013124","journal-title":"Brain Res"},{"key":"742_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0091-3022(02)00005-5","volume":"23","author":"JP Burbach","year":"2002","unstructured":"Burbach JP (2002) Regulation of gene promoters of hypothalamic peptides. Front Neuroendocrinol 23:342\u2013369","journal-title":"Front Neuroendocrinol"},{"key":"742_CR14","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.neuropsychologia.2010.05.019","volume":"48","author":"AJ Calder","year":"2010","unstructured":"Calder AJ, Keane J, Young AW et al (2010) The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington\u2019s disease. Neuropsychologia 48:2719\u20132729","journal-title":"Neuropsychologia"},{"key":"742_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.10.007","volume":"84","author":"HK Caldwell","year":"2008","unstructured":"Caldwell HK, Lee HJ, Macbeth AH, Young WS 3rd (2008) Vasopressin: behavioral roles of an \u201coriginal\u201d neuropeptide. Prog Neurobiol 84:1\u201324","journal-title":"Prog Neurobiol"},{"key":"742_CR16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/hmg\/11.8.945","volume":"11","author":"EY Chan","year":"2002","unstructured":"Chan EY, Nasir J, Gutekunst CA et al (2002) Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum Mol Genet 11:945\u2013959","journal-title":"Hum Mol Genet"},{"key":"742_CR17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuropharm.2009.12.004","volume":"58","author":"HE Covington 3rd","year":"2010","unstructured":"Covington HE 3rd, Vialou V, Nestler EJ (2010) From synapse to nucleus: novel targets for treating depression. Neuropharmacology 58:683\u2013693","journal-title":"Neuropharmacology"},{"key":"742_CR18","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"742_CR19","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","volume":"62","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Glascher J et al (2007) Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62:1187\u20131190","journal-title":"Biol Psychiatry"},{"key":"742_CR20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","volume":"32","author":"G Douaud","year":"2006","unstructured":"Douaud G, Gaura V, Ribeiro MJ et al (2006) Distribution of grey matter atrophy in Huntington\u2019s disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 32:1562\u20131575","journal-title":"Neuroimage"},{"key":"742_CR21","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/hmg\/ddh328","volume":"13","author":"I Dragatsis","year":"2004","unstructured":"Dragatsis I, Zeitlin S, Dietrich P (2004) Huntingtin-associated protein 1 (Hap1) mutant mice bypassing the early postnatal lethality are neuroanatomically normal and fertile but display growth retardation. Hum Mol Genet 13:3115\u20133125","journal-title":"Hum Mol Genet"},{"key":"742_CR22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007) Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry 62:1341\u20131346","journal-title":"Biol Psychiatry"},{"key":"742_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1254\/jphs.08R14FM","volume":"109","author":"N Egashira","year":"2009","unstructured":"Egashira N, Mishima K, Iwasaki K, Oishi R, Fujiwara M (2009) New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharmacol Sci 109:44\u201349","journal-title":"J Pharmacol Sci"},{"key":"742_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.1085","volume":"432","author":"CF Elias","year":"2001","unstructured":"Elias CF, Lee CE, Kelly JF et al (2001) Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 432:1\u201319","journal-title":"J Comp Neurol"},{"key":"742_CR25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","volume":"210","author":"AO Goodman","year":"2008","unstructured":"Goodman AO, Murgatroyd PR, Medina-Gomez G et al (2008) The metabolic profile of early Huntington\u2019s disease\u2014a combined human and transgenic mouse study. Exp Neurol 210:691\u2013698","journal-title":"Exp Neurol"},{"issue":"Pt 11","key":"742_CR26","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/120.11.2029","volume":"120","author":"JM Gray","year":"1997","unstructured":"Gray JM, Young AW, Barker WA, Curtis A, Gibson D (1997) Impaired recognition of disgust in Huntington\u2019s disease gene carriers. Brain 120(Pt 11):2029\u20132038","journal-title":"Brain"},{"key":"742_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","volume":"147","author":"HJ Gundersen","year":"1987","unstructured":"Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229\u2013263","journal-title":"J Microsc"},{"key":"742_CR28","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H et al (1999) Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci 19:2522\u20132534","journal-title":"J Neurosci"},{"key":"742_CR29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1096\/fasebj.13.9.1099","volume":"13","author":"MO Hebb","year":"1999","unstructured":"Hebb MO, Denovan-Wright EM, Robertson HA (1999) Expression of the Huntington\u2019s disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J 13:1099\u20131106","journal-title":"FASEB J"},{"key":"742_CR30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/brain\/awh165","volume":"127","author":"A Hennenlotter","year":"2004","unstructured":"Hennenlotter A, Schroeder U, Erhard P et al (2004) Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington\u2019s disease. Brain 127:1446\u20131453","journal-title":"Brain"},{"key":"742_CR31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","volume":"68","author":"ES Herndon","year":"2009","unstructured":"Herndon ES, Hladik CL, Shang P et al (2009) Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains. J Neuropathol Exp Neurol 68:250\u2013261","journal-title":"J Neuropathol Exp Neurol"},{"key":"742_CR32","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00670.2007","volume":"294","author":"JW Hill","year":"2008","unstructured":"Hill JW, Elmquist JK, Elias CF (2008) Hypothalamic pathways linking energy balance and reproduction. Am J Physiol Endocrinol Metab 294:E827\u2013E832","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"742_CR33","doi-asserted-by":"crossref","unstructured":"Hult S, Schultz K, Soylu R, Petersen A (2010) Hypothalamic and neuroendocrine changes in Huntington\u2019s disease. Curr Drug Targets (Epub ahead of print)","DOI":"10.2174\/1389450111007011237"},{"key":"742_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V et al (2008) Huntington\u2019s disease: from pathology and genetics to potential therapies. Biochem J 412:191\u2013209","journal-title":"Biochem J"},{"key":"742_CR35","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","volume":"65","author":"TR Insel","year":"2010","unstructured":"Insel TR (2010) The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65:768\u2013779","journal-title":"Neuron"},{"key":"742_CR36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/brain\/awm107","volume":"130","author":"SA Johnson","year":"2007","unstructured":"Johnson SA, Stout JC, Solomon AC et al (2007) Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington\u2019s disease. Brain 130:1732\u20131744","journal-title":"Brain"},{"key":"742_CR37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","volume":"78","author":"CL Julien","year":"2007","unstructured":"Julien CL, Thompson JC, Wild S et al (2007) Psychiatric disorders in preclinical Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 78:939\u2013943","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"742_CR38","first-page":"213","volume":"75","author":"J Kassubek","year":"2004","unstructured":"Kassubek J, Juengling FD, Kioschies T et al (2004) Topography of cerebral atrophy in early Huntington\u2019s disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 75:213\u2013220","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"742_CR39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.mp.4001638","volume":"10","author":"T Kishi","year":"2005","unstructured":"Kishi T, Elmquist JK (2005) Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry 10:132\u2013146","journal-title":"Mol Psychiatry"},{"key":"742_CR40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.coph.2009.10.006","volume":"9","author":"A Kleinridders","year":"2009","unstructured":"Kleinridders A, Konner AC, Bruning JC (2009) CNS-targets in control of energy and glucose homeostasis. Curr Opin Pharmacol 9:794\u2013804","journal-title":"Curr Opin Pharmacol"},{"key":"742_CR41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","volume":"435","author":"M Kosfeld","year":"2005","unstructured":"Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005) Oxytocin increases trust in humans. Nature 435:673\u2013676","journal-title":"Nature"},{"key":"742_CR42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","volume":"93","author":"S Kotliarova","year":"2005","unstructured":"Kotliarova S, Jana NR, Sakamoto N et al (2005) Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem 93:641\u2013653","journal-title":"J Neurochem"},{"key":"742_CR43","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.peptides.2006.03.032","volume":"27","author":"EO Koylu","year":"2006","unstructured":"Koylu EO, Balkan B, Kuhar MJ, Pogun S (2006) Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides 27:1956\u20131969","journal-title":"Peptides"},{"key":"742_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6123(08)64576-8","volume":"93","author":"HP Kremer","year":"1992","unstructured":"Kremer HP (1992) The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases. Prog Brain Res 93:249\u2013261","journal-title":"Prog Brain Res"},{"key":"742_CR45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","volume":"49","author":"HP Kremer","year":"1990","unstructured":"Kremer HP, Roos RA, Dingjan G, Marani E, Bots GT (1990) Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease. J Neuropathol Exp Neurol 49:371\u2013382","journal-title":"J Neuropathol Exp Neurol"},{"key":"742_CR46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","volume":"132","author":"HP Kremer","year":"1991","unstructured":"Kremer HP, Roos RA, Dingjan GM et al (1991) The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease. Neurosci Lett 132:101\u2013104","journal-title":"Neurosci Lett"},{"key":"742_CR47","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A et al (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861","journal-title":"Hum Mol Genet"},{"key":"742_CR48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","volume":"65","author":"NM Lalic","year":"2008","unstructured":"Lalic NM, Maric J, Svetel M et al (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65:476\u2013480","journal-title":"Arch Neurol"},{"key":"742_CR49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","volume":"25","author":"R Landgraf","year":"2004","unstructured":"Landgraf R, Neumann ID (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25:150\u2013176","journal-title":"Front Neuroendocrinol"},{"key":"742_CR50","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","volume":"23","author":"SH Li","year":"2003","unstructured":"Li SH, Yu ZX, Li CL et al (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington\u2019s disease. J Neurosci 23:6956\u20136964","journal-title":"J Neurosci"},{"key":"742_CR51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"XJ Li","year":"1995","unstructured":"Li XJ, Li SH, Sharp AH et al (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398\u2013402","journal-title":"Nature"},{"key":"742_CR52","volume-title":"Atlas of the human brain","author":"J Mai","year":"2008","unstructured":"Mai J, Paxinos G, Voss T (2008) Atlas of the human brain. Academic Press, Oxford"},{"key":"742_CR53","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/ddn003","volume":"17","author":"S Metzger","year":"2008","unstructured":"Metzger S, Rong J, Nguyen HP et al (2008) Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington\u2019s disease. Hum Mol Genet 17:1137\u20131146","journal-title":"Hum Mol Genet"},{"key":"742_CR54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/da.20156","volume":"23","author":"E Miraglia del Giudice","year":"2006","unstructured":"Miraglia del Giudice E, Santoro N, Fiumani P et al (2006) Adolescents carrying a missense mutation in the CART gene exhibit increased anxiety and depression. Depress Anxiety 23:90\u201392","journal-title":"Depress Anxiety"},{"key":"742_CR55","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","volume":"2","author":"F Mochel","year":"2007","unstructured":"Mochel F, Charles P, Seguin F et al (2007) Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2:e647","journal-title":"PLoS One"},{"key":"742_CR56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000093215","volume":"55","author":"B Montagne","year":"2006","unstructured":"Montagne B, Kessels RP, Kammers MP et al (2006) Perception of emotional facial expressions at different intensities in early-symptomatic Huntington\u2019s disease. Eur Neurol 55:151\u2013154","journal-title":"Eur Neurol"},{"key":"742_CR57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","volume":"25","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Wood NI, Hastings MH et al (2005) Disintegration of the sleep\u2013wake cycle and circadian timing in Huntington\u2019s disease. J Neurosci 25:157\u2013163","journal-title":"J Neurosci"},{"key":"742_CR58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0306-4522(99)00433-9","volume":"95","author":"ID Neumann","year":"2000","unstructured":"Neumann ID, Torner L, Wigger A (2000) Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 95:567\u2013575","journal-title":"Neuroscience"},{"key":"742_CR59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mehy.2006.11.009","volume":"69","author":"CU Pae","year":"2007","unstructured":"Pae CU, Lee C, Paik IH (2007) Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression. Med Hypotheses 69:132\u2013135","journal-title":"Med Hypotheses"},{"key":"742_CR60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","volume":"24","author":"A Petersen","year":"2006","unstructured":"Petersen A, Bjorkqvist M (2006) Hypothalamic-endocrine aspects in Huntington\u2019s disease. Eur J Neurosci 24:961\u2013967","journal-title":"Eur J Neurosci"},{"key":"742_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","volume":"14","author":"A Petersen","year":"2005","unstructured":"Petersen A, Gil J, Maat-Schieman ML et al (2005) Orexin loss in Huntington\u2019s disease. Hum Mol Genet 14:39\u201347","journal-title":"Hum Mol Genet"},{"key":"742_CR62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000225377","volume":"6","author":"A Petersen","year":"2009","unstructured":"Petersen A, Hult S, Kirik D (2009) Huntington\u2019s disease\u2014new perspectives based on neuroendocrine changes in rodent models. Neurodegener Dis 6:154\u2013164","journal-title":"Neurodegener Dis"},{"key":"742_CR63","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mds.21971","volume":"23","author":"W Phillips","year":"2008","unstructured":"Phillips W, Shannon KM, Barker RA (2008) The current clinical management of Huntington\u2019s disease. Mov Disord 23:1491\u20131504","journal-title":"Mov Disord"},{"key":"742_CR64","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","volume":"131","author":"M Politis","year":"2008","unstructured":"Politis M, Pavese N, Tai YF et al (2008) Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study. Brain 131:2860\u20132869","journal-title":"Brain"},{"key":"742_CR65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","volume":"151","author":"V Popovic","year":"2004","unstructured":"Popovic V, Svetel M, Djurovic M et al (2004) Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease. Eur J Endocrinol 151:451\u2013455","journal-title":"Eur J Endocrinol"},{"key":"742_CR66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrn2493","volume":"9","author":"G Rogge","year":"2008","unstructured":"Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ (2008) CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 9:747\u2013758","journal-title":"Nat Rev Neurosci"},{"key":"742_CR67","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh N, Moutereau S, Durr A et al (2009) Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One 4:e4962","journal-title":"PLoS One"},{"key":"742_CR68","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.psyneuen.2007.12.004","volume":"33","author":"E Savaskan","year":"2008","unstructured":"Savaskan E, Ehrhardt R, Schulz A, Walter M, Schachinger H (2008) Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 33:368\u2013374","journal-title":"Psychoneuroendocrinology"},{"key":"742_CR69","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nm1382","volume":"12","author":"G Sheng","year":"2006","unstructured":"Sheng G, Chang GQ, Lin JY et al (2006) Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat Med 12:526\u2013533","journal-title":"Nat Med"},{"key":"742_CR70","doi-asserted-by":"crossref","unstructured":"Soneson C, Fontes M, Zhou Y et al (2010) Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis. doi: 10.1016\/j.nbd.2010.07.013","DOI":"10.1016\/j.nbd.2010.07.013"},{"key":"742_CR71","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuropsychologia.2005.07.003","volume":"44","author":"R Sprengelmeyer","year":"2006","unstructured":"Sprengelmeyer R, Schroeder U, Young AW, Epplen JT (2006) Disgust in pre-clinical Huntington\u2019s disease: a longitudinal study. Neuropsychologia 44:518\u2013533","journal-title":"Neuropsychologia"},{"key":"742_CR72","doi-asserted-by":"crossref","unstructured":"Sprengelmeyer R, Young AW, Calder AJ et al (1996) Loss of disgust. Perception of faces and emotions in Huntington\u2019s disease. Brain 119 (Pt 5):1647\u20131665","DOI":"10.1093\/brain\/119.5.1647"},{"key":"742_CR73","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.peptides.2006.01.027","volume":"27","author":"LM Stanek","year":"2006","unstructured":"Stanek LM (2006) Cocaine- and amphetamine related transcript (CART) and anxiety. Peptides 27:2005\u20132011","journal-title":"Peptides"},{"key":"742_CR74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0074-7696(04)40003-5","volume":"240","author":"DF Swaab","year":"2004","unstructured":"Swaab DF (2004) Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 240:305\u2013375","journal-title":"Int Rev Cytol"},{"key":"742_CR75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(96)00080-7","volume":"728","author":"HJ Timmers","year":"1996","unstructured":"Timmers HJ, Swaab DF, van de Nes JA, Kremer HP (1996) Somatostatin 1\u201312 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington\u2019s disease patients. Brain Res 728:141\u2013148","journal-title":"Brain Res"},{"key":"742_CR76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","volume":"20","author":"A Trejo","year":"2004","unstructured":"Trejo A, Tarrats RM, Alonso ME et al (2004) Assessment of the nutrition status of patients with Huntington\u2019s disease. Nutrition 20:192\u2013196","journal-title":"Nutrition"},{"key":"742_CR77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Lutz Y, Stevanin G et al (1995) Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature 378:403\u2013406","journal-title":"Nature"},{"key":"742_CR78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuron.2009.12.007","volume":"65","author":"AE Twelvetrees","year":"2010","unstructured":"Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL et al (2010) Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65:53\u201365","journal-title":"Neuron"},{"key":"742_CR79","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","volume":"129","author":"BR Underwood","year":"2006","unstructured":"Underwood BR, Broadhurst D, Dunn WB et al (2006) Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 129:877\u2013886","journal-title":"Brain"},{"key":"742_CR80","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.neuropsych.19.4.441","volume":"19","author":"E Duijn van","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19:441\u2013448","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"742_CR81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0079-6123(08)00422-6","volume":"170","author":"AH Veenema","year":"2008","unstructured":"Veenema AH, Neumann ID (2008) Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res 170:261\u2013276","journal-title":"Prog Brain Res"},{"key":"742_CR82","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.parkreldis.2008.10.002","volume":"15","author":"A Videnovic","year":"2009","unstructured":"Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM (2009) Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord 15:471\u2013474","journal-title":"Parkinsonism Relat Disord"},{"key":"742_CR83","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"742_CR84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","volume":"22","author":"MJ West","year":"1999","unstructured":"West MJ (1999) Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 22:51\u201361","journal-title":"Trends Neurosci"},{"key":"742_CR85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2009.02.010","volume":"34","author":"S Wiehager","year":"2009","unstructured":"Wiehager S, Beiderbeck DI, Gruber SH et al (2009) Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety. Neurobiol Dis 34:375\u2013380","journal-title":"Neurobiol Dis"},{"key":"742_CR86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","volume":"76","author":"NI Wood","year":"2008","unstructured":"Wood NI, Goodman AO, van der Burg JM et al (2008) Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse. Brain Res Bull 76:70\u201379","journal-title":"Brain Res Bull"},{"key":"742_CR87","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","volume":"19","author":"T Yamanaka","year":"2010","unstructured":"Yamanaka T, Tosaki A, Miyazaki H et al (2010) Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction. Hum Mol Genet 19:2099\u20132112","journal-title":"Hum Mol Genet"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0742-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-010-0742-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0742-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T05:30:40Z","timestamp":1711776640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0742-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0742-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}